Company: XTIA
Filing Date: 2025-03-31
Form Type: 424B5
Source: 0001013762-25-004458
Chunk: 14

Company: XTI Aerospace, Inc.
Filing Date: 2025-03-31
Form: 424B5
Chunk 14
---
 connection with the January 2025 offering and was paid a
$525,000 cash fee upon the closing of such offering.

Compliance with Nasdaq Continued Listing Requirements

On February 11, 2025, we received
a letter from The Nasdaq Stock Market LLC (“Nasdaq”) confirming that we have regained compliance with the minimum bid price
requirement set forth under Nasdaq Listing Rule 5550(a)(2), and accordingly, the Nasdaq Hearings Panel has determined to continue the
listing of our common stock on Nasdaq.

Estimated Preliminary Operational Results for the Fourth Quarter and Year Ended December 31, 2024

We are currently in the process
of finalizing our consolidated financial results for our fourth quarter and year ended December 31, 2024 and, therefore, our actual results
for these periods are not yet available and have not been audited. Presented below are certain estimated preliminary operational results
for the fourth quarter and year ended December 31, 2024 that are subject to change pending finalization. As such, our actual results may
differ materially from the estimated preliminary results presented in this prospectus supplement and will not be finalized until after
we complete our normal year-end accounting procedures, which will occur after the consummation of this offering. Our preliminary results
set forth below reflect management’s best estimate of the impact of events during the year and are based on the information currently
available to us as of the date of this prospectus supplement.

Accordingly, undue reliance
should not be placed on these preliminary estimates. These preliminary estimates are not necessarily indicative of any future period and
should be read together with the sections titled “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors”
and under similar headings in the documents incorporated by reference into this prospectus supplement and the accompanying prospectus
as well as our financial statements, related notes and other financial information incorporated by reference into this prospectus supplement.

We estimate our total revenue
for the three months and year ended December 31, 2024, to be approximately $1.0 million and $3.2 million, respectively. We estimate our
operating expenses for the three months and year ended December 31, 2024, to be approximately $10.6 million and to $38.9 million, respectively.
We estimate our cash and cash equivalents and outstanding debt balance as of December 31, 2024, to be approximately $4.1 million and $